Ventas, Inc. $VTR Shares Sold by BDF Gestion

BDF Gestion trimmed its holdings in shares of Ventas, Inc. (NYSE:VTR) by 17.2% in the third quarter, Holdings Channel reports. The firm owned 47,902 shares of the real estate investment trust’s stock after selling 9,960 shares during the period. BDF Gestion’s holdings in Ventas were worth $3,353,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in VTR. Vanguard Group Inc. lifted its stake in shares of Ventas by 4.1% during the second quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after purchasing an additional 2,854,751 shares in the last quarter. State Street Corp raised its holdings in shares of Ventas by 5.2% during the 2nd quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock valued at $1,781,267,000 after buying an additional 1,388,678 shares during the period. Geode Capital Management LLC lifted its position in Ventas by 4.9% during the 2nd quarter. Geode Capital Management LLC now owns 12,226,283 shares of the real estate investment trust’s stock worth $769,061,000 after acquiring an additional 574,663 shares in the last quarter. Resolution Capital Ltd boosted its holdings in Ventas by 10.5% in the 1st quarter. Resolution Capital Ltd now owns 7,889,848 shares of the real estate investment trust’s stock worth $542,506,000 after acquiring an additional 751,587 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in Ventas by 4.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 6,414,404 shares of the real estate investment trust’s stock valued at $441,056,000 after acquiring an additional 281,232 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

VTR has been the topic of a number of recent research reports. Weiss Ratings cut shares of Ventas from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday. Argus reaffirmed a “buy” rating and set a $75.00 price target on shares of Ventas in a research note on Tuesday, August 26th. Citigroup upped their price objective on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Raymond James Financial restated an “outperform” rating and set a $78.00 target price (up from $74.00) on shares of Ventas in a research note on Friday, August 22nd. Finally, Scotiabank boosted their price target on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 13th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Ventas has an average rating of “Moderate Buy” and an average target price of $79.31.

Insider Buying and Selling

In other Ventas news, CEO Peter J. Bulgarelli sold 3,924 shares of Ventas stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $75.00, for a total value of $294,300.00. Following the completion of the transaction, the chief executive officer owned 112,564 shares of the company’s stock, valued at $8,442,300. The trade was a 3.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Debra A. Cafaro sold 317,258 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $74.24, for a total transaction of $23,553,233.92. Following the sale, the chief executive officer owned 1,145,695 shares of the company’s stock, valued at approximately $85,056,396.80. The trade was a 21.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 688,184 shares of company stock worth $50,726,248 over the last ninety days. 0.80% of the stock is owned by insiders.

Ventas Price Performance

VTR opened at $79.13 on Friday. The company has a market capitalization of $37.17 billion, a P/E ratio of 152.18, a PEG ratio of 2.02 and a beta of 0.78. The company has a 50-day moving average of $76.06 and a 200-day moving average of $69.79. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.32 and a current ratio of 0.32. Ventas, Inc. has a 1-year low of $56.68 and a 1-year high of $81.89.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period last year, the firm earned $0.80 earnings per share. The company’s revenue for the quarter was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Equities analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be given a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Wednesday, December 31st. Ventas’s dividend payout ratio is currently 369.23%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.